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HAGHJOO, M., ET AL.: Optimal Side of Implant for Single-Lead VDD Pacing: Right-Sided Versus Left-
Sided Implantation. Background: Atrial undersensing occurs in a considerable number of patients with
single-lead VDD pacing. This study tried to determine the role of implant side in maintenance of the VDD
mode in patients with isolated atrioventricular (AV) block.
Methods: Eighty-two patients with isolated AV block (46 females; mean age, 58 ± 17 years) received
a single-lead VDD pacemaker (Medtronic Kappa, n = 70 and St. Jude Medical Affinity, n = 12). The
patients were randomly assigned to one of two implantation groups (group I: right-sided VDD and group
II: left-sided VDD). In each group, the P-wave amplitudes were determined at implantation, predischarge,
2-month, and 6-month follow-up. At each follow-up visit, stored event histograms of pacemaker were also
retrieved. The atrial sensing measurements were compared between two groups.
Results: Implantation was easier from right side (1.7 ± 1.0 vs 2.8 ± 1.7 attempts, P = 0.001). Implant
P-wave was higher in group I compared to group II (4.2 ± 1.7 vs 2.7 ± 1.0 mV, P < 0.0001). During follow-
up, higher P-wave amplitudes were obtained in group I both at predischarge (2.6 ± 1.3 vs 1.4 ± 1.1 mV,
P < 0.0001), 2-month (2.8 ± 1.8 vs 1.3 ± 1.0 mV, P < 0.0001), and 6-month (2.9 ± 1.7 vs 1.3 ± 0.9 mV,
P < 0.0001) evaluations but remained stable throughout the 6 months in both groups. After implantation,
VDD function was better maintained in group I than group II (100% vs 90%, P = 0.026). Incidence of atrial
undersensing was lower in group I than group II (P = 0.026) in last follow-up visit.
Conclusions: Implant side has a significant influence on atrial sensing performance in single-lead VDD
pacing. Thus, right-side implantation should be the preferred approach for the implantation of VDD
single-lead systems. (PACE 2005; 28:384–390)
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Introduction
Since its introduction in the early 1970s,1
single-lead VDD pacing has become a reliable al-
ternative to DDD systems for patients with var-
ious degrees of atrioventricular (AV) block and
normal sinus node function. It offers long-term re-
liable sensing and makes the implanter’s work both
simpler and quicker.2 Although every attempt has
been made for improving atrial sensing function
of single-lead VDD pacing by selecting the right
candidate patient,3 positioning of atrial dipole in
proper location,4 using electrodes with different
designs,5 activating autosensing algorithm,6 and
programming the most sensitive setting for atrial
sensing,7 intermittent atrial undersensing remains
a problem in this pacing system.8 Consequently,
the identification of methods contributing to a
better performance of single-lead VDD pacemaker
would be desirable. We, therefore, investigated the
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role of implant side, which hitherto has not been
systematically investigated, in the maintenance of
AV synchrony in single-lead VDD pacing system.
Patients and Methods
Patient’s Characteristics
Between August 2002 and September 2003, 82
consecutive patients with symptomatic or high de-
gree AV block were enrolled in this study. The
patients were randomly assigned to receive ei-
ther right-sided or left-sided VDD implantation
(group I: right-side implantation and group II: left-
side implantation). The study was approved by lo-
cal ethics committee, and written informed con-
sents were obtained from all the patients. Mean
age at implantation was 58 ± 17 years (range 12–
82 years), and 56% of the patients were females.
Pacemaker indication was complete AV block in
67.0%, second-degree AV block in 28.0%, and
trifascicular block in 5%. At the time of pace-
maker implantation, structural heart disease was
present in 57.3% of the patients. Coronary artery
disease or a history of coronary artery bypass graft-
ing was present in 22.0% of the patients. Con-
genital AV block was present in 11.0% of the pa-
tients, 2.3% of the patients received pacemaker as
a complication of cardiac surgery, and 22.0% of the
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patients suffered from systemic arterial hyperten-
sion. Idiopathic (senescent) AV block was found
in 42.7% of the patients. Inclusion criteria of this
study were: (1) second- or third-degree AV block
and (2) normal sinus node function as evidenced
by sinus rate ≥90 bpm at rest in patients with sta-
ble AV block and sinus rate ≥70 bpm in the cases
of trifascicular block.9−11 Patients were excluded
if there was evidence of (1) sinus node dysfunc-
tion, (2) a history of paroxysmal supraventricular
tachyarrhythmia,11,12 and (3) cardiomegaly espe-
cially right heart dilation (right atrium dimension
>38 mm).11,12
Pacing System
Two different VDD pacing systems were im-
planted for the patients: Medtronic Kappa VDD
701 (Minneapolis, MN, USA) with Capsure 5038
lead (n = 70) and St. Jude Medical Affinity VDR
5430 (St. Paul, MN, USA) with AV PLUS DX 1368
lead (n = 12). These devices were capable of re-
porting the percentage of paced and sensed beats
in the atrium and ventricle. All the pacemakers
were programmed for bipolar sensing with atrial
sensitivities between 0.10 and 0.18 mV.
The Medtronic Capsure 5038 and St. Jude
AV PLUS DX 1368 are bifurcated, bipolar, coax-
ial, silicone-insulated, tined, and steroid-eluting
leads equipped with floating atrial ring dipole. The
Medtronic 5038 lead is available in three differ-
ent models according to the distance between the
atrial ring dipole and the distal ventricular elec-
trode (A-V spacing): 11.5, 13.5, and 15.5. In these
leads, the ventricular tip and ring electrode con-
sisted of platinum alloy with a surface area of
5.8 mm2 and 36 mm2, respectively. Two rings of
platinum alloy with a surface area of 12.5 mm2
each and a distance of 8.6 mm were used for atrial
sensing. The 58 cm lead length with 13.5 cm A-V
spacing was the only one used in our study from
Medtronic Capsure 5038 leads. The St. Jude AV
PLUS DX 1368 lead is available in lengths of 52,
58, and 65 cm. In these leads, the ventricular tip
and ring electrode consisted of platinum-iridium
with a surface area of 5.0 mm2 and 32 mm2, respec-
tively. Two rings of platinum-iridium with inter-
electrode distance of 11.9 mm were used for atrial
sensing. Lead length of 58 cm with A-V spacing 13
cm was used in our study from St. Jude AV PLUS
DX leads.
Implantation Technique
Devices were implanted in electrophysiology
laboratory using standard implant techniques with
local anesthetic. All the patients were in sinus
rhythm at the time of implantation. Implanting
physicians were all qualified electrophysiologists.
The lead was inserted through the subclavian vein
(right-side 50% and left-side 50%) using a 9 or
10 French peel-away sheath. The choice of im-
plantation site was randomized. In this study, no
cephalic vein approach was used because we gen-
erally prefer to employ subclavian vein as the
venous access in our electrophysiology labora-
tory and we have also had difficulty in traversing
relatively large diameter VDD leads through the
cephalic vein in some of our prior patients. Af-
ter the placement of VDD lead in right ventricular
apex and obtaining adequate sensing and pacing
thresholds, atrial sensing was assessed by atrial
mapping: Firstly, the proximal part of the lead was
moved backwards in the direction of the supe-
rior vena cava (SVC). Then, the atrial dipole was
bowed to move distally in an inferior direction to-
ward the middle part of the right atrium (avoiding
from low right atrium because of report of higher
incidence of atrial undersensing in several pub-
lished studies).4,7−9,13 Priority was placed on ob-
taining maximum mean atrial sensing amplitude
during shallow and deep breathing. At optimal
atrial dipole location, the stability of mean atrial
sensing amplitude was checked using maneuvers
such as deep inspiration and coughing. Atrial and
ventricular sensing and pacing thresholds were
determined using pacing system analyzer (PSA)
5311 (Medtronic Inc.). In all the instances, ana-
lyzer display informations were used to measure
P-wave amplitude, R-wave amplitude, impedance,
and stimulation threshold. The acceptable atrial
signal amplitude measured via the atrial channel
was ≥1.5 mV (or minimal P-wave ≥1.0 mV11), both
in shallow and deep breathing. The acceptable val-
ues for ventricular sensing and pacing thresholds
were ≥5.0 mV and ≤1.0 V, respectively. The atrial
dipole repositioning was required if atrial signal
amplitude was <1.5 mV. Finally, lead was secured
using the sleeve immediately outside the puncture
site and anchored to VDD pulse generator. All the
cases were checked for atrial dipole displacement
under fluoroscopy before pocket closure. All the
pacemakers were programmed at a lower rate of 40
beats/min, sensed AV interval of 150 ms and upper
tracking rate of 120–140 beats/min depending on
the age and level of physical activity. Atrial sen-
sitivity was set at highest sensitivity value (0.10–
0.18 mV).11 Isometric exercise of upper extremities
was done to check for myopotential oversensing by
atrial dipole.
Follow-Up
Atrial signal amplitude was measured dur-
ing shallow and deep breathing in the supine
position at predischarge (24 hour), 2 and 6
months after implantation. Medtronic 9790 and
St. Jude 3510/3500 programmers were used to
measure atrial signal amplitude, monitor P-wave
PACE, Vol. 28 May 2005 385
HAGHJOO, ET AL.
Figure 1. An example of stored event histogram of VDD
pacemaker. This histogram reports the percentage of
AS-VS, AS-VP, VP, and PVE in all counted beats. This
percentage can be used to calculate the percentage of
atrioventricular synchrony.
undersensing and retrieve stored event histogram
(Fig. 1) in follow-up visits.
Definitions
Atrial undersensing was defined by the pres-
ence of one of the following criteria: (1) evidence
of less than 95% AV synchrony in event his-
togram of pacemaker, (2) loss of detection of at
least one P-wave during shallow and deep breath-
ing in the supine position indicated by surface
electrocardiogram (ECG) and telemetered marker
annotations, and (3) P-wave amplitude ≤0.10–
0.18 mV at each follow-up visit. Significant atrial
undersensing was characterized by any symp-
tomatic undersensing needing reprogramming to
VVIR mode or upgrading to DDD mode. Asymp-
tomatic atrial undersensing refers to any episodes
of atrial undersensing needing no intervention due
to low clinical relevance. Ventricular pacing with
no preceding atrial sensed event (VP) was con-
sidered as improper function of the VDD system,
while atrial sensing-ventricular sensing (AS-VS)
and atrial sensing-ventricular pacing (AS-VP) in-
dicated proper AV synchrony.
Statistical Analysis
Data are presented as mean ± SD and ranged
when appropriate. Continuous variables were
compared by Student’s t-test. Comparison of cate-
gorical variables was done by χ2-test. A P value <
0.05 was defined statistically significant. The soft-
ware SPSS version 11.0 (SPSS Inc., Chicago, IL,
USA) was used for statistical analysis.
Results
Eighty-two consecutive patients having var-
ious degrees of isolated AV block were entered
in our study. Each studied group consisted of 41
patients, who received single-lead VDD pacing.
The preimplant characteristics of all included pa-
tients are presented in Table I. A comparison of
the two study groups showed no statistically sig-
nificant difference in clinical characteristics and
implanted devices (Table I).
Measurements at Implant
At implant, P-wave amplitude measured by
PSA was 3.4 ± 1.6 mV (range, 1.5–8.6 mV). PSA
P-wave amplitude was 2.7 ± 1.0 mV in group II
compared to 4.2 ± 1.7 mV in group I (P < 0.0001).
A P-wave amplitude ≥1.5 mV was achieved in all
the patients. The minimum/mean/maximum val-
ues of atrial signals were summarized in Table II.
The ventricular pacing threshold was 0.50 ± 0.32
mV at 0.5 ms in group I compared to 0.47 ± 0.34
mV at 0.5 ms in group II (P = 0.24). The ventric-
ular impedance and R-wave amplitude were, re-
spectively, 711 ± 133  and 11.2 ± 3.0 mV (P =
0.42) in group I compared to 683 ± 122  and
11.1 ± 3.3 mV (P = 0.50) in group II. The mean
number of attempts for atrial dipole positioning
from the right side was 1.7 ± 1.0 compared to
2.8 ± 1.7 in left side (P = 0.001). Finally, atrial
dipole was placed in mid-right atrium in all the
patients of both groups (100%).
Measurements at Predischarge
At predischarge, P-wave amplitude measured
by programmer was 2.0 ± 1.3 mV (range, 0.18–
5.6 mV). Programmer-determined P-wave ampli-
tude was 1.4 ± 1.1 mV in group II versus 2.6 ± 1.3
mV in group I (P < 0.0001). In both groups, a 40%
diminution was seen between values obtained at
implant with a PSA and those determined by the
programmer at predischarge. The percentage of AV
synchrony was not significantly different between
the two groups at this stage (99% in group I vs 98%
in group II), although a trend was seen for better
AV synchronization in group I (P = 0.07).
Measurements at 2 Months Postimplantation
Two months after implantation, sensed P-
wave amplitude, determined by programmer, was
2.1 ± 1.6 mV (range, 0.10–7.0 mV). A statistically
significant difference was seen in atrial signal am-
plitude between the two groups (group I: 2.8 ±
1.8 mV and group II: 1.3 ± 1.0 mV; P < 0.0001)
at 2-month follow-up visit. Percentage of AV syn-
chrony was 99% in group I compared to 94% in
group II (P < 0.0001).
Measurements at 6 Months Postimplantation
Electrical measurements of 6 months postim-
plantation were similar to those of 2-month follow-
up (2.1 ± 1.6 mV; range, 0.10–7.0 mV). P-wave am-
plitude was 2.9 ± 1.7 mV in group I compared to
1.3 ± 0.9 mV in group II (P < 0.0001). Difference
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Table I.
Preimplant Patient Characteristics
Variable Total Group I* Group II* P value
Number of patients 82 41 41
Male/female (no.) 36/46 17/24 19/22 0.60
Age (years, mean ± SD) 58 ± 17 57 ± 16 59 ± 18 0.59
Resting sinus rate (beats/min, mean ± SD) 97.6 ± 7.5 96.9 ± 5.4 99.6 ± 7.4 0.076
Ejection fraction (%, mean ± SD) 49.9 ± 6.0 50.5 ± 5.9 49.4 ± 6.2 0.408
Underlying heart disease (no.)
Ischemic 18 10 8 0.51
Hypertensive 18 8 10 0.52
Congenital 9 4 5 0.49
Postoperative 2 1 1 0.53
Idiopathic 35 18 17 0.52
Pacemaker indication (%)
Third-degree AVB† 67.0 57.5 77.5 0.125
Second-degree AVB 28.0 37.5 17.5 0.129
Trifascicular block 5 5 5 0.124
Pacing system model (no.)
Medtronic Kappa 701 70 33 37 0.35
St. Jude Medical Affinity 12 8 4 0.34
Follow-up duration (months) 6 6 6
*Group I: right-sided VDD; Group II: left-sided VDD.
†AVB = atrioventricular block.
between the percentages of AV synchrony of the
two groups was statistically significant (group I,
99% vs group II, 93%; P < 0.0001).
Atrial Sensing Over Time
In each group, the mean values of the atrial
signal measured at predischarge were statistically
lower (P < 0.0001) than those determined under
same conditions at implantation. No significant
differences were found in mean atrial signal ampli-
tude between predischarge and at 2-month follow-
Table II.
Minimal/Mean/Maximum P-wave Amplitude Measured at
the Implantation
Group I Group II P value
Minimal P-wave 2.44 ± 1.0 1.72 ± 0.69 <0.0001
amplitude (mV)
Maximum P-wave 5.12 ± 1.9 3.5 ± 1.34 <0.0001
amplitude (mV)
Mean P-wave 4.2 ± 1.7 2.7 ± 1.0 <0.0001
amplitude (mV)
Group I: right-sided implantation; Group II: left-sided
implantation.
up (P = 0.18). The mean values of atrial signal am-
plitude were not different between 2 and 6 months
after implantation (P = 0.26), although a trend was
seen for the improvement of atrial sensing function
in group I over time.
Maintenance of VDD Mode
Of the 82 patients studied, 6 (7%) were no
longer in VDD mode at their last follow-up visit
because of significant atrial undersensing despite
programming of highest atrial sensitivity. These
patients required reprogramming to VVIR mode.
Upgrading was not considered beneficial in any
patient. Intermittent asymptomatic atrial under-
sensing occurred in additional 2 patients. Two pa-
tients (1 patient in each group) with atrial un-
dersensing had displacement of atrial dipole to
SVC at 2-month follow-up visits. Remaining 6
patients belong to group II (without evidence of
dipole displacement in any direction). In those
patients without atrial dipole displacement, there
was statistically significant difference in the main-
tenance rate of VDD mode between the two groups
(90% in group II vs 100% in group I, P = 0.026).
Fortunately, no patient required reprogramming
because of the development of atrial tachyarrhyth-
mias or sinus node dysfunction. The average
percentage of AV synchrony in patients who
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were in VDD mode was 98%, 96%, and 96% at
predischarge, 2- and 6-month follow-up visits, re-
spectively. There were statistically significant dif-
ferences in the percentage of AV synchronization
between the two groups at 2- and 6-month follow-
up (P < 0.0001).
Pacing Outcome
Intermittent atrial undersensing occurred in 3
(3.6%) VDD patients at predischarge in spite of the
programming of the device to the highest atrial sen-
sitivity. Chest x-ray revealed no evidence of atrial
dipole displacement in any directions (from the
position at implantation) in these patients. Repro-
gramming was not done at this time because of low
clinical relevance. No other early complications
occurred in our patients. At the first 2 months, 8
(9.7%) patients showed intermittent atrial under-
sensing. Of these patients, 6 (7%) patients needed
reprogramming to VVIR mode because of inade-
quate atrial sensing and symptomatic sinus brady-
cardia. Two of six patients with atrial undersens-
ing (1 patient in each implantation group) showed
displacement of atrial dipole to SVC. Remaining
4 patients (all from group II) had no evidence
of dipole displacement. No other lead-related or
implant-related complications were observed at
this time. At the last follow-up visit, no new ev-
idence of atrial undersensing was seen in any pa-
tients. We also had no new device-related compli-
cations. During 6-month follow-up, no evidence of
sinus node dysfunction or atrial tachyarrhythmia
was found in our study population. There were sta-
tistically significant differences in the incidence of
atrial undersensing at 2- and 6-month follow-up
visits between the two-implantation groups (P =
0.026).
Discussion
As its introduction, VDD pacing has been used
increasingly in patients with AV block and nor-
mal sinus node function. The reliability of this
pacing system has been demonstrated in several
studies.9,11,12,14,15 However, due to a great varia-
tion of the atrial potential received by free-floating
electrodes16 and instability of atrial dipole during
changes in posture,17,18 intermittent atrial under-
sensing remains a potential problem in single-lead
VDD pacing. Many studies have tried to define the
predictors of long-term failure of VDD pacing and
to test the effects of new sensing algorithm and
dipole design on the incidence of atrial undersens-
ing.5,6 Recently, Choi et al.17 suggested an inter-
esting technique using chest x-ray for preimplant
prediction of posture dependent changes in atrial
sensing performance of VDD pacemaker. These ef-
forts have somewhat been effective in the mainte-
nance of proper VDD function, but atrial under-
sensing has persisted. Until now, no systematic
study has focused on the role of implantation side
on atrial sensing function of single-lead VDD pac-
ing. We conducted a prospective study to address
this issue.
Implantation Side and Procedural Difficulties
Even though lead tip positioning in RV apex is
usually easier from the left side than that the right
side, in our study right-sided VDD implantation
was accomplished easier than left-sided implanta-
tion regarding to the number of attempts for atrial
dipole positioning. Lesser attempts at dipole po-
sitioning could lead to the shortening of implant
time in group I, albeit implant time was not cal-
culated in our patients. In both groups, similarly
acceptable electrical parameters were achieved in
the right ventricle at implantation.
Implantation Side and Atrial Sensing Function
There was a significant decrease in atrial sig-
nal amplitude, measured by PSA and telemetry on
the next day after implantation. No difference was
found among the serial measurements of atrial sig-
nal after implantation and during follow-up vis-
its. These results are in keeping with the findings
of other studies.12,15 The reason for the observed
drop in atrial signal amplitude between PSA and
telemetry measurements may be related to equip-
ment differences, including not only the ampli-
fiers, but also the difference in the sampling meth-
ods and blanking capabilities of the two different
instruments.2 Although the above-mentioned pat-
tern of serial atrial signal changes was seen in both
studied groups, atrial signal measurements were
always in favor of group I, both at implantation
and follow-up visits. The average percentage of
AV synchrony in patients who were in VDD mode
was 96% at the last follow-up visit. Previous stud-
ies have reported both somewhat lower and higher
AV synchrony from 93.7%3 to 99.7%.19 There was
a statistically significant difference in the percent-
age of AV synchronization between the two groups
at the last follow-up (P < 0.0001). More impor-
tantly, 93% of the pacemakers functioned satis-
factorily in the VDD mode, with only 7% of the
patients dropping out for significant atrial under-
sensing. The maintenance rate of VDD mode was
similar to that of the findings of European mul-
ticenter study by Crick et al.20 There was a sta-
tistically significant difference in the maintenance
rate of VDD between the two groups (P = 0.026).
Our hypothesis for a better outcome of VDD pac-
ing in group I is the presence of an extra-bend
of lead in SVC dragging the atrial dipole to close
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Figure 2. Postoperative fluoroscopy of a patient with
right-sided VDD pacemaker. Note the extra-bending of
lead in SVC drags the atrial dipole to close proximity of
atrial wall.
proximity of the right atrial (RA) wall (Fig. 2). Close
proximity to RA lateral wall leads to better atrial
sensing function because the distance between the
dipole and the atrial wall is the key factor for
stable sensitivity.12 Although it might be possible
to design such an extra-bend of lead from the left,
this maneuver is simpler and easier from the right.
We also believe that formation of such an extra-
bend against the SVC wall from the right side leads
to stabilization of atrial dipole in mid-part of RA
(an optimal location for atrial dipole) but trying to
make a similar bend from the left could displace
the atrial dipole to low RA (a location with accept-
able acute atrial signal amplitude but considerable
atrial undersensing4,7−9,13).
Implantation Side and Incidence of Atrial
Undersensing
Intermittent atrial undersensing was seen in
3.6% of our patients in predischarge evaluation
despite programming of highest atrial sensitivity.
This may be explained by using mean P-wave am-
plitude instead of minimal P-wave amplitude (a
better predictor of undersensing) in our analyses.
All of the patients were completely asymptomatic
at this stage, thus needing no intervention. Two
months after implantation, incidence of atrial un-
dersensing increased to 9.7%. Six patients became
symptomatic because of bradycardia, necessitating
reprogramming of pacemaker mode. There was a
statistically significant difference in the incidence
of atrial undersensing between the two groups,
both at predischarge and follow-up visits (P =
0.026). Our overall incidence of significant atrial
undersensing was comparable to that in the find-
ings of other studies.3,4,21,22 We have not observed
any episodes of pacemaker-mediated or ventricu-
lar tachycardia and atrial fibrillation during obser-
vation period. The rarity of atrial fibrillation in our
study might be related to the protective effect of
VDD pacemaker11 and relatively short follow-up
duration. As symptomacy of VDD patients is not
strictly related to the frequency of atrial undersens-
ing, it is desirable to avoid any kind of atrial un-
dersensing in single-lead VDD pacemakers. Right-
sided VDD implantation is a new idea in achieving
this goal.
Limitations
Our study was limited as a result of its reliance
on the event counter of pacemaker to evaluate the
percentage of AV synchrony. However, a compar-
ative evaluation of sensing function between the
groups was done by a combined use of atrial sig-
nal amplitude, telemetered ECG, event histogram,
sinus rate, spontaneous AV conduction, and clini-
cal data at each visit. Reliability of this combined
evaluation has been noted previously.23 Our study
duration is relatively short, explaining partially no
case of atrial fibrillation and sinus node dysfunc-
tion during follow-up. However, the stability of
postimplantation atrial sensing measurements has
been documented previously.15
Conclusions and Clinical Implications
In accordance with previous studies, single-
lead VDD pacing is an effective and reliable pac-
ing option in selected patients with AV block and
normal sinus node function. Implant side has sig-
nificant influence on improving atrial sensing per-
formance and maintaining AV synchronization in
single-lead VDD pacemakers. Right-sided VDD has
a much better atrial sensing function, both in short-
and long-term evaluations. Therefore, right-sided
implantation can be recommended to improve the
performance of VDD pacing. However, confirma-
tion of these findings in a larger patient popula-
tion is reasonable to determine general implanta-
tion guidelines.
PACE, Vol. 28 May 2005 389
HAGHJOO, ET AL.
References
1. Chamberlain DA, Wollons DJ, White HM, et al. Synchronous A-V
pacing with a single pervenous electrode. (abstract) Br Heart J 1973;
35:559.
2. Ovsyshcher I, Katz A, Bondy C. Clinical evaluation of a new single-
pass lead VDD pacing system. PACE 1994; 17:1859–1864.
3. Pakarinen S, Toivonen L. Pre-implant determinants of adequate
long-term function of single lead VDD pacemakers. Europace 2002;
4:137–141.
4. Wiegand UKH, Nowak B, Reisp U, et al. Implantation strategy of
the atrial dipole impacts atrial sensing performance of single lead
VDD pacemakers. PACE 2002; 25:316–323.
5. Lau CP, Leung SK, Lee ISF. Comparative evaluation of acute
and long-term clinical performance of two single lead atrial syn-
chronous ventricular (VDD) pacemakers: Diagonally arranged bipo-
lar versus closely spaced bipolar ring electrodes. PACE 1996; 19(Pt.
I):1574–1581.
6. Nowak B, Fellmann P, Maertens S, et al. First experience with an
automatic sensing algorithm in single-lead VDD stimulation. PACE
1998; 21(Pt. II):2232–2235.
7. Wiegand UKH, Schneider R, Bode F, et al. Atrial sensing and
AV-synchrony in single-lead VDD pacemakers. Is the occur-
rence of atrial undersensing predictable? Z Kardiol 1997; 86:95–
104.
8. Toivonen L, Lommi J. Dependence of atrial sensing function on pos-
ture in a single-lead atrial triggered ventricular (VDD) pacemaker.
PACE 1996; 19:309–313.
9. Ovsyshcher IE. Single-lead VDD/DDD pacing reality and perspec-
tives. Folia Cardiologica 1998; 5:91–98.
10. Wiegand UKH, Bode F, Schneider R, et al. Development of sinus
node disease in patients with AV block: Implications for single lead
VDD pacing. Heart 1999; 81:580–585.
11. Ovsyshcher IE, Crystal E. VDD pacing: underevaluated, underval-
ued, and underused. PACE 2004; 27:1335–1338.
12. Santini M, Ricci R, Pignalberi C, et al. Immediate and long-term
atrial sensing stability in single-lead VDD pacing depends on right
atrial dimensions. Europace 2001; 3:324–331.
13. Hunziker P, Buser P, Pfisterer M, et al. Predictors of loss of atrioven-
tricular synchrony in single lead VDD pacing. Heart 1998; 80:390–
392.
14. Huang M, Krahn AD, Yee R, et al. Optimal pacing for symptomatic
AV block: A comparison of VDD and DDD pacing. PACE 2004;
27:19–23.
15. Ovsyshcher I, Katz A, Rosenheck S, et al. Single lead VDD pacing:
Multicenter study. PACE 1996; 19(Pt. II):1768–1771.
16. Sun ZH, Stjernvall J, Laine P, et al. Extensive variation in the signal
amplitude of the atrial floating VDD pacing electrode. PACE 1998;
21:1760–1765.
17. Choi K-J, Nam G-B, Kim J, et al. Can chest roentgenogram predict
the posture dependent changes of atrial sensing performance in
patients with a VDD pacemaker? PACE 2004; 27:1339–1343.
18. Kuzniec J, Golovchiner G, Mazur A, et al. Atrial sensing measure-
ments in VDD systems according to body position. PACE 2004;
27:1344–1346.
19. Leibold A, Merk J, Keyl C, et al. Clinical results with single lead
VDD pacemaker. Eur J Cardiothoracic Surgery 1997; 11:722–727.
20. Crick JCP. European multicenter prospective follow-up study of
1002 implants of a single lead VDD pacing system. PACE 1991;
14:1742–1744.
21. Wiegand UKH, Bode F, Schneider R, et al. Atrial sensing and AV
synchrony in single lead VDD pacemakers: A prospective compar-
ison to DDD devices with bipolar atrial leads. J Cardiovasc Electro-
physiol 1999; 10:513–520.
22. Chamberlain-Webber R, Barnes E, Papouchado M, et al. Long-term
survival of VDD pacing. PACE 1998; 21:2246–2248.
23. Israel CW, Bockenforde JB. Pacemaker event counters: Possible
sources of error in calculation of AV synchrony in VDD single lead
systems as an example for present limitations. PACE 1998; 21:489–
493.
390 May 2005 PACE, Vol. 28
